The new codes, 37X47 and 37X48, describe percutaneous transcatheter renal sympathetic denervation procedures and are expected to become effective January 1, 2028.
The new codes, 37X47 and 37X48, describe percutaneous transcatheter renal sympathetic denervation procedures and are expected to become effective January 1, 2028.
MENLO PARK, Calif.--(BUSINESS WIRE)--Inquis Medical, a medical device company pioneering advanced treatments for venous thromboembolic disease, today announced the U.S. commercial launch of the latest AVENTUS™ Catheter, designed to provide...
MENLO PARK, Calif.--(BUSINESS WIRE)--Inquis Medical, a medical device company pioneering advanced treatments for venous thromboembolic disease, today announced the U.S. commercial launch of the latest AVENTUS™ Catheter, designed to provide...
Open-Motion uses near-infrared light to measure changes in blood flow and blood volume beneath tissue surfaces in real time without invasive procedures.
Open-Motion uses near-infrared light to measure changes in blood flow and blood volume beneath tissue surfaces in real time without invasive procedures.
WINREVAIR, an activin signaling inhibitor, is FDA-approved for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1 pulmonary hypertension) to improve exercise capacity and WHO functional class (FC), and reduce the...
WINREVAIR, an activin signaling inhibitor, is FDA-approved for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1 pulmonary hypertension) to improve exercise capacity and WHO functional class (FC), and reduce the...
Mölnlycke Health Care US, LLC. has launched a new surgical glove range designed to reduce clinician hand exposure to scattered radiation during fluoroscopy-guided, interventional and other image-dependent procedures.
Mölnlycke Health Care US, LLC. has launched a new surgical glove range designed to reduce clinician hand exposure to scattered radiation during fluoroscopy-guided, interventional and other image-dependent procedures.
Physicians now have immediate access to the SELUTION SLR™ DEB, a next-generation drug-eluting balloon designed to deliver sustained sirolimus therapy without leaving a permanent implant behind.
Physicians now have immediate access to the SELUTION SLR™ DEB, a next-generation drug-eluting balloon designed to deliver sustained sirolimus therapy without leaving a permanent implant behind.
An international team of researchers, working closely with scientists at the universities of Zurich and Greifswald, has developed and validated a diagnostic scoring system designed to identify Takotsubo syndrome before cardiac catheterization...
An international team of researchers, working closely with scientists at the universities of Zurich and Greifswald, has developed and validated a diagnostic scoring system designed to identify Takotsubo syndrome before cardiac catheterization...
The new hybrid cardiac catheterization lab is a 730-square-foot suite equipped with advanced imaging equipment to perform complex minimally invasive procedures with greater precision, such as Transcatheter Aortic Valve Repair (TAVR),...
The new hybrid cardiac catheterization lab is a 730-square-foot suite equipped with advanced imaging equipment to perform complex minimally invasive procedures with greater precision, such as Transcatheter Aortic Valve Repair (TAVR),...
Researchers followed more than 6,000 adults for 10 years and found that, for the overall study population, adding a coronary artery calcium score provided only a small improvement over PREVENT, the American Heart Association's primary...
Researchers followed more than 6,000 adults for 10 years and found that, for the overall study population, adding a coronary artery calcium score provided only a small improvement over PREVENT, the American Heart Association's primary...
